GONZALEZ RICHARD A

Track

Insider profile

Performance

Overall performance
2.7
Performance over holding periods
2.7
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 22% 68% 82%
Transactions
205 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
GONZALEZ RICHARD A's trades of Abbvie Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-22 2025-08-22
US Abbvie Inc (ABBV)
PrS Proposed sale
20,138
57.74
US$1,844,315 		20,138 57.74 US$1,844,315
2025-08-21 2025-08-21
US Abbvie Inc (ABBV)
PrS Proposed sale
32,308
420.62
US$1,915,814 		32,308 420.62 US$1,915,814
2025-08-08 2025-08-04
US Abbvie Inc (ABBV)
PrS Proposed sale
69,292
262.12
US$3,060,335 		69,292 262.12 US$3,060,335
2025-08-08 2025-08-04
US Abbvie Inc (ABBV)
PrS Proposed sale
35,120
194.43
US$6,828,296 		35,120 194.43 US$6,828,296
2025-08-08 2025-08-01
US Abbvie Inc (ABBV)
PrS Proposed sale
61,500
195.83
US$12,043,268 		61,500 195.83 US$12,043,268
2025-03-04 2025-03-03
US Abbvie Inc (ABBV)
S Sale
6,168 -1.6%
210.53
US$1,298,549 		6,168 -1.6% 210.53 US$1,298,549
2025-03-03 2025-03-03
US Abbvie Inc (ABBV)
PrS Proposed sale
6,168
210.53
US$1,298,550 		6,168 210.53 US$1,298,550
2025-03-04 2025-02-28
US Abbvie Inc (ABBV)
S Sale
92,460 -19.0%
205.11
US$18,964,471 		92,460 -19.0% 205.11 US$18,964,471
2025-02-28 2025-02-28
US Abbvie Inc (ABBV)
PrS Proposed sale
92,460
205.11
US$18,964,882 		92,460 205.11 US$18,964,882
2024-08-07 2024-08-05
US Abbvie Inc (ABBV)
S Sale
66,500 -13.0%
186.52
US$12,403,580 		66,500 -13.0% 186.52 US$12,403,580
2024-08-05 2024-08-05
US Abbvie Inc (ABBV)
PrS Proposed sale
66,500
187.36
US$12,459,360 		66,500 187.36 US$12,459,360
2024-07-19 2024-07-17
US Abbvie Inc (ABBV)
S Sale
282,845 -35.5%
175.00
US$49,497,875 		282,845 -35.5% 175.00 US$49,497,875
2024-07-17 2024-07-17
US Abbvie Inc (ABBV)
PrS Proposed sale
282,845
175.00
US$49,497,875 		282,845 175.00 US$49,497,875
2024-03-01 2024-02-28
US Abbvie Inc (ABBV)
S Sale
138,616 -21.1%
177.27
US$24,572,458 		138,616 -21.1% 177.27 US$24,572,458
2024-02-28 2024-02-28
US Abbvie Inc (ABBV)
PrS Proposed sale
138,616
177.28
US$24,573,663 		138,616 177.28 US$24,573,663
2023-08-02 2023-08-01
US Abbvie Inc (ABBV)
S Sale
60,000 -9.6%
148.58
US$8,914,800 		60,000 -9.6% 148.58 US$8,914,800
2023-08-02 2023-07-31
US Abbvie Inc (ABBV)
S Sale
18,500 -2.9%
149.15
US$2,759,275 		18,500 -2.9% 149.15 US$2,759,275
2023-07-31 2023-07-31
US Abbvie Inc (ABBV)
PrS Proposed sale
80,500
150.85
US$12,143,425 		80,500 150.85 US$12,143,425
2023-07-31 2023-07-31
US Abbvie Inc (ABBV)
PrS Proposed sale
80,500
150.85
US$12,143,425 		80,500 150.85 US$12,143,425
2021-12-10 2021-12-09
US Abbvie Inc (ABBV)
S Sale
109,624 -22.5%
123.48
US$13,535,911 		109,624 -22.5% 123.48 US$13,535,911
2021-12-10 2021-12-09
US Abbvie Inc (ABBV)
S Sale
64,476 -11.7%
122.80
US$7,917,730 		64,476 -11.7% 122.80 US$7,917,730
2021-03-02 2021-03-01
US Abbvie Inc (ABBV)
S Sale
631 -0.2%
109.33
US$68,984 		631 -0.2% 109.33 US$68,984
2021-03-02 2021-03-01
US Abbvie Inc (ABBV)
S Sale
169,482 -31.0%
108.61
US$18,407,220 		169,482 -31.0% 108.61 US$18,407,220
2020-11-12 2020-11-12
US Abbvie Inc (ABBV)
S Sale
16,171 -4.8%
97.49
US$1,576,493 		16,171 -4.8% 97.49 US$1,576,493
2020-11-12 2020-11-12
US Abbvie Inc (ABBV)
S Sale
177,983 -34.7%
97.06
US$17,275,297 		177,983 -34.7% 97.06 US$17,275,297
2020-11-12 2020-11-09
US Abbvie Inc (ABBV)
S Sale
37,450 -10.5%
95.74
US$3,585,463 		37,450 -10.5% 95.74 US$3,585,463
2018-12-13 2018-12-11
US Abbvie Inc (ABBV)
S Sale
16,850 -5.6%
88.75
US$1,495,438 		16,850 -5.6% 88.75 US$1,495,438
2018-03-02 2018-02-28
US Abbvie Inc (ABBV)
S Sale
8,280 -2.6%
117.88
US$976,084 		8,280 -2.6% 117.88 US$976,084
2017-11-24 2017-11-21
US Abbvie Inc (ABBV)
S Sale
218,193 -44.3%
94.01
US$20,511,800 		218,193 -44.3% 94.01 US$20,511,800
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
1,200 -0.4%
71.03
US$85,236 		1,200 -0.4% 71.03 US$85,236
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
9,618 -3.3%
71.01
US$682,974 		9,618 -3.3% 71.01 US$682,974
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
446 -0.2%
71.04
US$31,682 		446 -0.2% 71.04 US$31,682
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
3,158 -1.1%
71.02
US$224,281 		3,158 -1.1% 71.02 US$224,281
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
2,602 -0.9%
71.04
US$184,846 		2,602 -0.9% 71.04 US$184,846
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
1,100 -0.4%
71.05
US$78,150 		1,100 -0.4% 71.05 US$78,150
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
157,163 -34.8%
71.00
US$11,158,573 		157,163 -34.8% 71.00 US$11,158,573
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
1,800 -0.4%
71.06
US$127,908 		1,800 -0.4% 71.06 US$127,908
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
1,153 -0.3%
71.02
US$81,880 		1,153 -0.3% 71.02 US$81,880
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
6,200 -1.3%
71.05
US$440,510 		6,200 -1.3% 71.05 US$440,510
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
3 -0.0%
71.07
US$213 		3 -0.0% 71.07 US$213
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
100 -0.0%
71.06
US$7,106 		100 -0.0% 71.06 US$7,106
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
1,809 -0.4%
71.03
US$128,484 		1,809 -0.4% 71.03 US$128,484
2017-08-08 2017-08-07
US Abbvie Inc (ABBV)
S Sale
6,779 -1.4%
71.01
US$481,343 		6,779 -1.4% 71.01 US$481,343
2017-08-04 2017-08-04
US Abbvie Inc (ABBV)
S Sale
737 -0.3%
71.13
US$52,423 		737 -0.3% 71.13 US$52,423
2017-08-04 2017-08-04
US Abbvie Inc (ABBV)
S Sale
200 -0.1%
71.11
US$14,222 		200 -0.1% 71.11 US$14,222